(Q50683556)

English

Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection

scientific article published in December 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

Craig Niederberger

2

object named as

Craig Niederberger

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

author name string

Ettore Caroppo

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

Giovanni Michele Vizziello

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

Giuseppe D'Amato

4

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

80

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

6

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

1398-1403

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

Effects of long-term treatment with human pure follicle-stimulating hormone on semen parameters and sperm-cell ultrastructure in idiopathic oligoteratoasthenozoospermia

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae 11)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Sperm deoxyribonucleic acid fragmentation is increased in poor-quality semen samples and correlates with failed fertilization in intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Sperm chromatin anomalies can influence decondensation after intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Sperm nuclear DNA damage and altered chromatin structure: effect on fertilization and embryo development

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Pure follicle-stimulating hormone as an adjuvant therapy for selected cases in male infertility during in-vitro fertilization is beneficial

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Sex chromosomal abnormalities and intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Incidence of chromosomal aberrations in children born after assisted reproduction through intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Prospective follow-up study of 877 children born after intracytoplasmic sperm injection (ICSI), with ejaculated epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Genetic anomaly and ICSI.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Polymorphism of human pituitary FSH: analysis of immunoreactivity and in vitro bioactivity of different molecular species

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

FSH in the treatment of oligozoospermia

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Inhibin B levels in azoospermic subjects with cytologically characterized testicular pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Serum Inhibin B in Combination with Serum Follicle-Stimulating Hormone (FSH) Is a More Sensitive Marker Than Serum FSH Alone for Impaired Spermatogenesis in Men, But Cannot Predict the Presence of Sperm in Testicular Tissue Samples

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

Possible role of pure human follicle-stimulating hormone in the treatment of severe male-factor infertility by assisted reproduction: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902202-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(03)02202-7

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/14667875

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50683556&oldid=2256801515"